GSK PLC header image

GSK PLC

GSK

Equity

ISIN null / Valor 120042705

New York Stock Exchange, Inc (2026-10-05)
USD 46.55-1.02%

GSK PLC
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

GSK PLC is a global healthcare company specializing in pharmaceuticals and vaccines, dedicated to preventing and treating a wide range of diseases. The company operates through key therapeutic areas including respiratory, immunology and inflammation, oncology, as well as HIV and other infectious diseases. Notably, GSK majority-owns ViiV Healthcare, the sole company exclusively focused on HIV treatment and prevention, aiming to end the HIV epidemic. With a robust portfolio of over 20 marketed vaccines, GSK delivers more than one million vaccine doses daily, addressing infectious diseases across all age groups. The company's approach emphasizes early intervention and the use of advanced technologies to support healthcare systems and improve patient outcomes. GSK's commitment to responsible business practices underpins its strategy for long-term growth and trust-building with stakeholders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

7.38%1Y
28.7%3Y
-2.54%5Y

Performance

27.3%1Y
64.2%3Y
52.1%5Y

Volatility

Market cap

93263 M

Market cap (USD)

Daily traded volume (Shares)

3,480,791

Daily traded volume (Shares)

1 day high/low

34.04 / 33.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
3.00
Théo Coupat
Switzerland, 02 Oct 2026
star star star star star
Interesting molecules in their pipeline that are in the later satges of development leading to potential high effects on the stock itself

EQUITIES OF THE SAME SECTOR

Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%USD 93.30
Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%USD 87.23
Illumina Inc
Illumina Inc Illumina Inc Valor: 1111080
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.56%USD 293.69
Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.74%USD 5.91
IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.05%USD 266.09
Medtronic PLC
Medtronic PLC Medtronic PLC Valor: 25187155
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.84%USD 87.97
LivaNova PLC
LivaNova PLC LivaNova PLC Valor: 28726218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.81%USD 76.43
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%CHF 52.90
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.02%USD 83.26
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc Zimmer Biomet Holdings Inc Valor: 1262932
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.72%USD 91.57